From the Napa Valley Register:
American scientists are recruiting seniors to take part in government-funded testing aimed at determining if a component in red wine may help combat Alzheimer’s disease.
The first-of-a-kind study will examine whether or not resveratrol can alter or delay the destruction of the brain in people with mild to moderate Alzheimer’s disease.
“Alzheimer’s is not an overnight process,” according to Laurie Ryan, program director for the National Institute on Aging’s Alzheimer’s Disease Clinical Trials program. She told reporters that “symptoms don’t appear until years after the disease has started. So the thought is if we can delay it from starting or progressing, we can add quality years to the end of life.”
NIH officials indicate 5.4 million Americans have Alzheimer’s, a fatal illness that has no treatment or cure.
The nation will spend an estimated $200 billion this year on caregiving for people with Alzheimer’s, including $140 billion for Medicare and Medicaid, according to an annual report from the Alzheimer’s Association. The report predicts costs will reach $1.1 trillion by 2050.
The progressive mind-wasting disease is the sixth leading cause of death in the United States, and the only cause of death among the top 10 that cannot be prevented or cured, association officials said.
For more, see: Will wine prove helpful in combating Alzheimer’s?